Careology partners with Entia to offer at home blood monitoring

Careology has partnered with Entia to integrate at-home blood monitoring into its digital cancer care platform, allowing patients to self-manage more of their treatment from home.

Under the deal, Entia’s Liberty, a UK-approved at-home full blood count analyser, will be incorporated into Careology’s platform. The integration will enable patients to conduct blood tests at home, with clinicians remotely monitoring how they respond to treatment.

Careology’s digital platform is used across the UK and US to support patients and cancer care teams in managing symptoms, medication schedules, and side effects. It also provides access to supportive care services. The integration with Liberty will add remote blood monitoring alongside existing indicators such as temperature, heart rate, and medication adherence.

Clinicians are able to access the data through the Careology Professional dashboard, enabling early intervention and care closer to home.

Paul Landau, founder and CEO of Careology (pictured) said the partnership aims to enhance the patient experience and reduce the strain on health systems. ‘A cancer diagnosis can be very daunting, with a schedule full of appointments and check-ins which can be both mentally and physically draining. By providing patients with self-service tools, they are able to feel less restricted by treatment and enable their cancer teams to monitor their progress remotely, enabling more oversight and early intervention.’

Entia developed Liberty in collaboration with The Christie NHS Foundation Trust and The Royal Marsden NHS Foundation Trust to meet the needs of cancer patients.

Dr Toby Basey-Fisher, founder and CEO of Entia, said: ‘This collaboration marks a significant step forward in patient empowerment, allowing individuals to manage their health with greater ease and autonomy. By integrating our technology with Careology’s platform, we can help to drive efficiencies in the healthcare system by not only enhancing the patient experience but also supporting clinical teams with valuable, holistic data insights.’